Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Aug 1;162(2):472-86.
doi: 10.1084/jem.162.2.472.

Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes

Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes

K Oshimi et al. J Exp Med. .

Abstract

After depletion of monocytes, natural killer (NK) cells were partially purified from peripheral blood by Percoll density gradient sedimentation. The NK cells were then cultured for 1 d and assayed for their cytotoxicity against various types of normal and malignant target cells. All types of target cells tested were found to be susceptible to NK cells. The susceptible targets were autologous T and B lymphocytes, mitogen-induced T and B blasts, monocytes, large granular lymphocytes, autologous or allogeneic lymphoma and leukemia cells isolated from patients, and cultured cell lines, including those resistant to interferon-activated lymphocytes. Such a broad spectrum of cytotoxicity was demonstrated in 1 d of culture, and freshly prepared NK cells were not cytotoxic, or, if anything, were less cytotoxic. Monocytes and their supernatants, added throughout the course of culture, markedly inhibited the development of their cytotoxicity. These results may suggest that, although NK cells having ability to lyse autologous normal and malignant target cells are present in vivo, their lytic activity is regulated by coexisting monocytes.

PubMed Disclaimer

References

    1. Int J Immunopharmacol. 1981;3(3):227-32 - PubMed
    1. J Exp Med. 1981 Jun 1;153(6):1582-91 - PubMed
    1. J Immunol. 1982 Mar;128(3):1031-6 - PubMed
    1. Scand J Immunol. 1981 Nov;14(5):555-63 - PubMed
    1. J Clin Invest. 1982 Apr;69(4):876-88 - PubMed